Cas:3453-99-4 2,2-Dimethoxybutane manufacturer & supplier

Chemical Name:2,2-Dimethoxybutane

CAS.NO:3453-99-4

Synonyms:Butan-2-on-dimethylacetal;butanone dimethyl ketal;Butane,2,2-dimethoxy;Ethylmethylketon-dimethylketal;Methylaethylketon-dimethylacetal;2,2-dimethoxy-butane;2,2-Dimethyoxy Butane;butan-2-one-dimethylacetal

Molecular Formula:C₆H₁₄O₂

Molecular Weight:118.17400

HS Code:2911000000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:99.8ºC at 760mmHg

Density:0.841g/cm3

Index of Refraction:1.39

PSA:18.46000

Exact Mass:118.09900

LogP:1.40540

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Butan-2-on-dimethylacetal chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,butan-2-one-dimethylacetal physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethylmethylketon-dimethylketal Use and application,2,2-dimethoxy-butane technical grade,usp/ep/jp grade.

Related News: FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 2,2-Dimethoxybutane manufacturer Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities. 2,2-Dimethoxybutane supplier Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. 2,2-Dimethoxybutane vendor FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 2,2-Dimethoxybutane factory Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.